President Donald Trump has announced a new milestone in lowering prescription drug prices for Americans, securing “Most Favored Nation” (MFN) agreements with nine additional pharmaceutical companies.
Tesla and SpaceX CEO Elon Musk has reignited debate over the future of work and money, declaring that advanced AI and robotics will soon render traditional savings—and even jobs—unnecessary.
